chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: HIBV
Symptoms: No adverse event, Product prescribing issue, Product use issue
Clinical narrative: prescribed a dose of ACTHIB for a patient for IgA deficiency, with no reported adverse event; prescribed a dose of ACTHIB for patient for IgA deficiency, with no reported adverse event; Initial information received on 05-Aug-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 48 years old female patient who was prescribed a dose of acthib for a patient for iga deficiency, with no reported adverse event , while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect HIB (PRP/T) VACCINE lot number not reported at an unknown dose via unknown route at an unknown administration site for immunization and  iga deficiency.  On an unknown date (latency: unknown), the patient developed a non-serious event of  prescribed a dose of acthib for a patient for iga deficiency, with no reported adverse event (product prescribing issue)(product use issue) following the administration of HIB (PRP/T) VACCINE.  Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the events .   Outcome: unknown for both events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 2.0
Sex: F
Vaccine: DTAPIPVHIB, IPV
Symptoms: Medication error
Clinical narrative: received pentacel vaccine and IPOL vaccine with no reported adverse event; Initial information received on 05-Aug-2022 regarding an unsolicited valid non-serious case received from health professional. (GMI Inquiry Number: 01223818)   This case involves a 2-year-old female patient who received DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] vaccine and IPV (VERO) [IPOL] vaccine with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis B vaccine for Immunization.  On 26-Jul-2022, the patient received suspect IPV (VERO) at dose 0.5 ml once (lot number not reported via unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the patient received suspect Pentacel Vaccine (unknown formulation, strength, dose, lot number, route in unknown administration site) for prophylactic vaccination.  Information regarding batch and expiry date requested.  On 26-JUL-2022 the patient received Pentacel vaccine and ipol vaccine with no reported adverse event (contraindicated product administered) same day latency.  Action taken: Not applicable for both suspects.  At time of reporting, the outcome was Unknown for the event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: MNQ
Symptoms: Extra dose administered, Medication error
Clinical narrative: medication error due to an extra dose in a short time frame wtih no reported adverse event; Initial information received on 05-Aug-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an Adolescent female patient who experienced medication error due to an extra dose in a short time frame wtih no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 05-Aug-2022, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (formulation, strength, dose, lot number not reported) via unknown route in unknown administration site for immunization.  On 05-Aug-2022, the patient had medication error due to an extra dose in a short time frame wtih no reported adverse event (extra dose administered) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  It was reported, "The pharmacist stated that he administered Menactra to a patient today, and then later the mom called and informed that her daughter had already received Menactra in Jun2022. The daughter therefore received two doses of Menactra within approximately two months. The pharmacist indicated that the patient was 17 or 18 years old".  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.33
Sex: F
Vaccine: IPV
Symptoms: Expired product administered
Clinical narrative: Expired dose of IPOL was given to a patient with no reported adverse event; Initial information received on 08-Aug-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 years old female patient who was administered expired dose of IPV (vero) [IPOL] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP); MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR); and VARICELLA ZOSTER VACCINE (VARICELLA VACCINE).  On 30-Jul-2022, the patient received 0.5 mL dose of suspect IPV (VERO) (lot T1D481M, expiry date: 25-Jul-2022; formulation, strength not reported) via intramuscular route in the left deltoid for immunization.  On 30-Jul-2022, the patient was administered expired dose of IPV (vero) [IPOL] with no reported adverse event (expired product administered).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. ; Sender's Comments:  01223666:
Age: 9.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Accidental exposure to product, No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: inadvertently received a dose of quadracel, with no reported adverse event; 9 year old female patient inadvertently received a dose of QUADRACEL with no adverse event; Initial information received on 08-Aug-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 9 years old female patient who advertently received a dose of quadracel, with no reported adverse event(Product administered to patient of inappropriate age, Accidental exposure to product) while receiving vaccine DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included varicella zoster vaccine (VARICELLA VACCINE) for Prophylactic vaccination.  On 03-Aug-2022, the patient received suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE at dose of 0.5 ml total (lot U7526AA, expiry date: 07-Sep-2024) via intramuscular route in the right deltoid for immunisation.  On 03-Aug-2022 the patient developed a non-serious 9 year old female patient inadvertently received a dose of quadracel with no adverse event (product administered to patient of inappropriate age), (accidental exposure to product) same day latency following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE.  Action taken: Not applicable.  Outcome: Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Dyspnoea, Malaise, Pulmonary thrombosis
Clinical narrative: Started having trouble breathing shortly after the Pfizer Booster Shot in November 2021.  Had a chest X-ray November/December 2021 Hospitalised after being taken extremely ill/struggling to breathe. Massive blood clot on lungs.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Inflammation, Obstructive airways disorder, Swelling
Clinical narrative: Within minutes of receiving the vaccine, I developed a cough and shortness of breath- told the nurses at clinic. I was sitting down and they put them me on the ground. My throat became itchy and my airway began closing. The nurses noted I developed hives on my chest and stomach.  A nurse gave me IM Epinephrine in my left thigh. It didn't not work for a couple of minutes (4-5 mins), so the nurses double checked the injection site to make sure it was administered (it was), as I didn't feel the injection. It did work after 4-5 minutes, and when EMS picked me up, I was still having throat itchiness, but improved.  I was taken to the ER via ambulance. My heart rate was in the 120-130s due to Epi. I did develop rebound shortness of breath, throat itchiness and a feeling of my throat closing again ~20 minutes later when I was waiting in the ER. The EMT told the triage RN and ~15 minutes later, I received IV Benadryl and IV Solumedrol.   I was told to take PO Benadryl or Xyxal for 48 hrs to help decrease inflammation. I took Xyxal mostly, for ~72 hrs, to be cautious. ............a week later I developed Shortness of breath, throat tightness and itchyness in a garden while holding a Maple Leaf. I was able to take liquid Benadryl, but had my Epi pen ready. My reaction to mosquito bites has worsened since, where the site will swell into a white hive, and I'll need to take Hydrocortisone to treat it. I've never had allergies to medications, leaves, and only mild itchiness at   mosquito bite sites.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Urticaria
Clinical narrative: Within minutes of receiving the vaccine, I developed a cough and shortness of breath- told the nurses at clinic. I was sitting down and they put them me on the ground. My throat became itchy and my airway began closing. The nurses noted I developed hives on my chest and stomach.  A nurse gave me IM Epinephrine in my left thigh. It didn't not work for a couple of minutes (4-5 mins), so the nurses double checked the injection site to make sure it was administered (it was), as I didn't feel the injection. It did work after 4-5 minutes, and when EMS picked me up, I was still having throat itchiness, but improved.  I was taken to the ER via ambulance. My heart rate was in the 120-130s due to Epi. I did develop rebound shortness of breath, throat itchiness and a feeling of my throat closing again ~20 minutes later when I was waiting in the ER. The EMT told the triage RN and ~15 minutes later, I received IV Benadryl and IV Solumedrol.   I was told to take PO Benadryl or Xyxal for 48 hrs to help decrease inflammation. I took Xyxal mostly, for ~72 hrs, to be cautious. ............a week later I developed Shortness of breath, throat tightness and itchyness in a garden while holding a Maple Leaf. I was able to take liquid Benadryl, but had my Epi pen ready. My reaction to mosquito bites has worsened since, where the site will swell into a white hive, and I'll need to take Hydrocortisone to treat it. I've never had allergies to medications, leaves, and only mild itchiness at   mosquito bite sites.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Dyspnoea, Hypersensitivity
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 2.0
Sex: M
Vaccine: UNK
Symptoms: Product preparation issue
Clinical narrative: Vaccine under constituted with 1.3 mLs diluent ie 5mcg/1.3mLs vaccine administered
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Vaccine under constituted with 1.3mLs of dilutent ie 5mcg/1.3mLs
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Vaccine under constituted ie 5mcg/1.3mLs
Age: 0.92
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Vaccine under constituted ie 5.cg/1.3mLs administered
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt is a 4 year old boy who would turn 5 between dose 2 and 3 of 6m-4y Pfizer primary series.  For that reason, in accordance with standing order, pt received Pfizer 5-11 as dose 1 three weeks ago per mother's educated choice.  Today, pt received his 2nd dose as Pfizer 6m-4y.  Provider was contacted and advised to administer the Pfizer 5-11 dose to complete the series at no minimum interval, per regulatory authority.   Mother was educated on risks/benefits/symptom management and agreed for pt to receive Pfizer 5-11 dose today as well.  Pt received Pfizer 5-11 dose and series is complete.
Age: 54.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: COVID-19, Computerised tomogram abnormal, Cough, Post-acute COVID-19 syndrome, SARS-CoV-2 test positive
Clinical narrative: Contracted Covid after the last injection.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Syncope
Clinical narrative: when checking out the patient fainted; was attended to by Dr after the incident and was placed in an exam room for about 30 min until she felt better
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Paranasal sinus discomfort, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: Contract COVID-19 during last week of June. Symptoms were a scratchy throat and sinus irritation/runny nose/nasal dripping in throat. Used Fluticasone Propionate once daily for four days, at which point symptoms were gone.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: Contract COVID-19 during last week of June. Symptoms were a scratchy throat and sinus irritation/runny nose/nasal dripping in throat. Used Fluticasone Propionate once daily for four days, at which point symptoms were gone.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 86.0
Sex: F
Vaccine: UNK
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: patient received pediatric pfizer dose and should have received adult pfizer dose
Age: 1.0
Sex: F
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: This vaccination was given instead of the MMR vaccine that was ordered.  Patient did not receive the MMR vaccine and is now waiting for that one.  Patient did not have a reaction to the vaccine and was observed for 15 minutes after.  Mother was spoken to later in the day and patient still was not having any reactions.  Mother was notified of the error and proper teaching was given to the nurse.
Age: 72.0
Sex: F
Vaccine: UNK
Symptoms: Incorrect product formulation administered
Clinical narrative: patient given pediatric pfizer dose and should have received adult pfizer dose
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Nausea
Clinical narrative: Pt went to the er because of elevated bp , nausease , and dizzy
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Malignant atrophic papulosis, Rash
Clinical narrative: I developed a rash on my chest soon after receiving the Booster Johnson and Johnson COVID shot. Pathology confirmed Malignant Atrophic Papulosis (Degos Disease). I am alerting you to this event because of the Extreme Rarity of Degos Disease. I find it an odd coincidence that I received the Johnson & Johnson COVID Booster Dec 8, 2021 and developed the rash in Jan 2022. My apologies if I have wasted your time.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 1.75
Sex: F
Vaccine: HIBV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received two doses of Pedvax Hib on 08/10/22 and it should have only been one dose. The patient had no adverse reactions.
Age: 20.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: Dizziness, Syncope
Clinical narrative: Patient became light headed and fainted
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 11.0
Sex: M
Vaccine: HPV9
Symptoms: Eye injury, Eyelid injury, Fall, Feeling abnormal, Immediate post-injection reaction
Clinical narrative: Patient had received TDAP in Left arm & did well. Then he had to have MCV4 & HPV. Patient was given MCV4 in RT arm first & did okay. Then patient got the HPV in a different area of Rt arm. During giving the HPV patient stated that it was burning and was painful. I kept talking to the patient. Asking him to breath and kept talking with him. He said he was better and then decided to stand. Once standing he said he wasn't feeling real good. So we had him sit back down on the chair. Patient was coherent and talking. I asked patient if he wanted a juice. He said yes. So I told mom to keep talking with him. I took 2 to 3 steps away & asked Covid nurse about either getting a juice or sitting with patient while I get one. It those seconds patient passed out. Patient slid out of chair & fell on the floor then hit his Left upper eye lid. He did have about 1/2 in laceration. Another nurse & I got him in save position. Applied pressure to the laceration. Patient came to quickly. We did ask mom to take patient to ER to be checked out.  Did call mom today 8/11/22- patient was doing better. Mom did not take him to the ER to checked.
Age: 11.0
Sex: M
Vaccine: HPV9
Symptoms: Injection site pain, Loss of consciousness
Clinical narrative: Patient had received TDAP in Left arm & did well. Then he had to have MCV4 & HPV. Patient was given MCV4 in RT arm first & did okay. Then patient got the HPV in a different area of Rt arm. During giving the HPV patient stated that it was burning and was painful. I kept talking to the patient. Asking him to breath and kept talking with him. He said he was better and then decided to stand. Once standing he said he wasn't feeling real good. So we had him sit back down on the chair. Patient was coherent and talking. I asked patient if he wanted a juice. He said yes. So I told mom to keep talking with him. I took 2 to 3 steps away & asked Covid nurse about either getting a juice or sitting with patient while I get one. It those seconds patient passed out. Patient slid out of chair & fell on the floor then hit his Left upper eye lid. He did have about 1/2 in laceration. Another nurse & I got him in save position. Applied pressure to the laceration. Patient came to quickly. We did ask mom to take patient to ER to be checked out.  Did call mom today 8/11/22- patient was doing better. Mom did not take him to the ER to checked.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Infection, Insomnia, Oropharyngeal pain, Paranasal sinus hypersecretion
Clinical narrative: I believe that I was exposed in a breakfast room in a hotel in country from 07/01/2022-07/03/2022. On 07/03 we flew from country to city. Around 8pm I noticed a sore throat. The next day, I had a slight fever of 99 degrees or so. I took an at home COVID-19 test which was positive. I tried to get in touch with an Urgent Care, but as it was 07/04/2022, no one was open. I was able to get in touch with my doctor on 07/05/2022. I had basically slept for roughly 24 hours. On 07/05/2022, I got a prescription for Paxlovid and I began taking it that evening. I took that for the recommended 5 days. During the course of the antiviral, I had a sore throat, elevated temperature for around 2 days, I was getting a lot of infection out of my sinuses but nothing in my chest. The infection was gone by the end of the Paxlovid course. After the Paxlovid course was complete, the infection returned for 2 days with no noticeable temperature. On 07/14/2022, I tested negative for COVID-19.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I believe that I was exposed in a breakfast room in a hotel in country from 07/01/2022-07/03/2022. On 07/03 we flew from country to city. Around 8pm I noticed a sore throat. The next day, I had a slight fever of 99 degrees or so. I took an at home COVID-19 test which was positive. I tried to get in touch with an Urgent Care, but as it was 07/04/2022, no one was open. I was able to get in touch with my doctor on 07/05/2022. I had basically slept for roughly 24 hours. On 07/05/2022, I got a prescription for Paxlovid and I began taking it that evening. I took that for the recommended 5 days. During the course of the antiviral, I had a sore throat, elevated temperature for around 2 days, I was getting a lot of infection out of my sinuses but nothing in my chest. The infection was gone by the end of the Paxlovid course. After the Paxlovid course was complete, the infection returned for 2 days with no noticeable temperature. On 07/14/2022, I tested negative for COVID-19.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 2 doses of Pfizer.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough admission after three vaccines Moderna 3/8/21 Lot# 023M20A;  Moderan 4/15/21 Lot# 025B21A;   Moderna 12/17/21 Lot# 031H21A;
Age: 16.0
Sex: M
Vaccine: MENB, MNQ, VARCEL
Symptoms: Dizziness, Pallor, Syncope
Clinical narrative: Approximately 5 minutes after vaccination, patient complained of feeling light-headed. His face appeared pale and he attempted to walk a couple of steps to get on the exam table and began to faint. He was caught by myself and his mother and guided to the floor without injury. The initial episode was very brief (seconds) and the patient was conscious and speaking by the time he was completely supine on the floor. He was provided a cool compress to the forehead for approximately 3 minutes until he felt able to stand to get to the table. Once flat on the table with legs raised, he was provided apple juice until he was able to sit and eventually stand and then walk to the car without light-headedness (approximately 20 minutes).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID  + on 7/17; admitted to hospital on 8/4 with weakness; Three vaccines: Moderna 2/11/21 Lot# 007M20A;  Moderna 3/11/21 Lot# 002B21A;  Moderna 10/27/21 Lot# 012F21A.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: External COVID + on 8/1; breakthrough admission on 8/5 after two vaccines Moderna 4/8/21 Lotz# 025B21A;  Moderna 5/6/21 Lot# 005C21A
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 3 doses of Moderna.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission (observation) after three vaccines: Pfizer 3/29/21  Lot# ER8734;  Pfizer 4/19/21  Lot# EW0161;  Pfizer 12/29/21 Lot# FJ8762.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Death, Dysphagia, Dysstasia, Erythema
Clinical narrative: Very bad throat, could not eat or drink, talking out of head, night and day, Started going into seizures in the emergency room of Medical center.  had ultrsound of leg for swelling and redness earlier.  Seizures for a month. Transferred to Care Center.  Had not treatment or medicaltions thereafter due to lockdown which was in process when the patient died.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Fluid intake reduced, Gait inability, Logorrhoea, Peripheral swelling
Clinical narrative: Very bad throat, could not eat or drink, talking out of head, night and day, Started going into seizures in the emergency room of Medical center.  had ultrsound of leg for swelling and redness earlier.  Seizures for a month. Transferred to Care Center.  Had not treatment or medicaltions thereafter due to lockdown which was in process when the patient died.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal disorder, Seizure, Ultrasound Doppler
Clinical narrative: Very bad throat, could not eat or drink, talking out of head, night and day, Started going into seizures in the emergency room of Medical center.  had ultrsound of leg for swelling and redness earlier.  Seizures for a month. Transferred to Care Center.  Had not treatment or medicaltions thereafter due to lockdown which was in process when the patient died.
Age: 0.33
Sex: M
Vaccine: HIBV
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: I accidentally administered a double dose of HIB, no adverse events have been reported. Mother was contacted by physician.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines Moderna 2/17/21 Lot# 006M20A;  Moderna 3/17/21 Lot# 001B21A;  Moderna 12/13/21 Lot# 58H21A
Age: 60.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Received Covid Vaccine.  Diagnosed with Covid.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after two vaccines Moderna 7/13/21 Lot# 051C21A;  Moderna 8/15/21 Lot#091D21A
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Raised hives on inside of right thigh and both arms.
Age: 1.17
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received his 3rd shot too early. He was supposed to receive it 9/29/2022. However, parent made online appointment, and Clinical staff didn't catch the error until vaccine was already administered.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after two vaccines: Moderna 3/26/21 Lot# 017B21A;  Moderna 4/23/21 Lot# 017B21A.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines Moderna 4/17/21 Lot# 048B21A;  Moderna 5/15/21 Lot# 048B21A;  Moderna 6/30/22 LOt# 054A22A
Age: 32.0
Sex: F
Vaccine: HEPA
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Pediatric dose given.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: pain, redness (4-5" oval), swelling, induration at injection sight, still present at 24 hrs
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: Resident received 5th dose of vaccine - had received doses 12/30/20, 1/20/21, 11/4/21, 5/25/22 and 8/10/22.  Resident monitored, no adverse reaction noted
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after two vaccines  Pfizer 4/7/21 Lot# not recorded;  Pfizer 5/5/21 Lot# not recorded
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Incorrect dilute used and incorrect volume of dilute.  0.7 ml sterile water used to dilute.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Diluted incorrectly. 0.7mL sterile water used.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 3 doses Pfizer
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: sore throat Tylenol, gargling with hot salted water Lasted about 5 days
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus
Clinical narrative: As of this day 8/11/2022 i still feel occasional pain and itchiness at injection site. Is it possible for the side effects to last this long?  I have felt this since recieving this injection which was the booster shot. I asked my doctor a d she was not sure. Please email me about this. Thanks.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Vaccine was incorrectly diluted.  0.7ml of sterile water was used.
Age: 49.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site induration, Injection site mass
Clinical narrative: Induration at injection site. Hardened lump approx 2cm in size lasting more than a week after injection
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Conjunctivitis, Eye pruritus, Eye swelling, Ocular hyperaemia
Clinical narrative: My son was telling me that his eye was itchy but I did not really think much of it. The next day they were still bugging him but they were both red and swollen. I was thinking maybe he had pink eye. We had a virtual visit with his doctor and they said it was a conjunctivitis. We have not gone anywhere and really cautious when we go out. I have not changed anything food, medication, or home product wise (laundry detergent etc.) other than that he had gotten his vaccine recently. The doctor had us to warm compresses on his eyes and eye drops.
Age: 92.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Patient admitted to hospital with COVID-19
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Cough, Fatigue, Neck pain
Clinical narrative: Developed COVID-19 about weeks after vaccination. Woke up with sore throat and persistent dry cough. I experienced sneezing, runny nose, fatigued and pain in back of neck and lower back. Went to walk in flu clinic and tested positive. Prescribed multi-symptom meds. Symptoms began resolving as soon as I began meds. Still experiencing extreme fatigue.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing
Clinical narrative: Developed COVID-19 about weeks after vaccination. Woke up with sore throat and persistent dry cough. I experienced sneezing, runny nose, fatigued and pain in back of neck and lower back. Went to walk in flu clinic and tested positive. Prescribed multi-symptom meds. Symptoms began resolving as soon as I began meds. Still experiencing extreme fatigue.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 54.0
Sex: F
Vaccine: COVID19, EBZR
Symptoms: Blood test abnormal, Computerised tomogram abnormal, Mesenteric panniculitis, Pancreatitis acute
Clinical narrative: Following my second dose on 2/8/21, I developed acute pancreatitis and Mesenteric panniculitis around 3/4/2021. Following my third dose on 7/22/22, I developed Mesenteric panniculitis again in early March of 2022.  My fourth dose of Pfizer was on 7/25/22 and beginning on 8/8/22 I am again having symptoms consistent with Mesenteric panniculitis.  When I developed pancreatitis in 2021, my doctors were not able to identify a specific cause such as medication or alcohol (I don't drink).
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, Dyspnoea, Headache, Pain
Clinical narrative: Moderna 7/3/2022 right deltoid, abdominal pain, sleep at 7 pm, 3 AM 103F and pounding headache, couldn't breathe due to shortness of breath unknown if anxiety. Back pain, sore. Past history. Fever until 2 PM. Local Pharmacy. Note will be placed in MyChart.  Moderna Covid-19 , mRNA, LNP-S, PF Vaccine lot number 014B22A.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Moderna 7/3/2022 right deltoid, abdominal pain, sleep at 7 pm, 3 AM 103F and pounding headache, couldn't breathe due to shortness of breath unknown if anxiety. Back pain, sore. Past history. Fever until 2 PM. Local Pharmacy. Note will be placed in MyChart.  Moderna Covid-19 , mRNA, LNP-S, PF Vaccine lot number 014B22A.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Moderna for 6 month to 4 years diluted. Patient had no reactions. No medical treatment needed.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Feeling abnormal, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: During the middle of night, I started having nasal dripping. I took a COVID-19 test and it was negative. By the afternoon I had a fever and congestion. I felt very bad. I had a fever for a couple of days. I was giving bebtelovimab treatment. I still have a lingering cough and congestion. My head feel a little better. On 8/5/2022, I tested for negative for COVID-19.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: During the middle of night, I started having nasal dripping. I took a COVID-19 test and it was negative. By the afternoon I had a fever and congestion. I felt very bad. I had a fever for a couple of days. I was giving bebtelovimab treatment. I still have a lingering cough and congestion. My head feel a little better. On 8/5/2022, I tested for negative for COVID-19.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given after the Beyond use date. No reactions were reported.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted to the hospital with COVID-19
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given after the beyond use date. No reactions were reported.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Rash
Clinical narrative: small regions of rashes present in varying locations associated with burning sensation
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood gases, Condition aggravated, Diplopia, Dyspnoea, Eye pain
Clinical narrative: 58 Y female with PMH of Graves Disease s/p thymectomy via median sternotomy (12/2012) on pyridostigmine, generalized anxiety disorder, and hx of frequent hospitalizations for myasthenia gravis flare ups transferred to the ICU on 8/5/2022 for myasthenia crisis. Patient states that she felt typical symptoms of her myasthenia crisis (weakness in her extremities, shortness of breath, and severe pain behind her left eye + blurry vision/diploplia) 40 minutes after receiving the Moderna vaccine this morning.   Per chart review, she has a recent history of hospitalization for myasthenia crisis s/p 3rd dose of Covid vaccine from 12/1/21 - 12/5/21 and other recent hospitalizations for regular flare ups from March 2022 and June 2022. The plan on discharge after her Covid induced flare up was to follow up with neurology prior to her next shot.   Compared to her previous flare up after a covid vaccine, she states that this episode has a quicker onset and she has less shortness of breath. Of note, she has been unable to take her PTA mestinon for the past 10 days after running out of her medications.   Endorses HA, eye pain Denies SOB, abd pain, chest pain, chills, nausea, vomiting, dysuria. Other ROS are negative unless otherwise stated in the HPI. Pt's NIF improved to -40 by next day with BLE weakness resolved and was stable to be transferred to the floors. Pt still had some residual L eye ptosis and pain, but no longer had any diplopia. Next day, pt's L eye ptosis has resolved completely, but she continued to have L eye pain. Pt initially was on: acetaminophen, PTA tramadol 50mg q6h, dialudid 0.2mg q4h PRN. However, pt's pain was still not controlled when dilaudid 0.2mg was changed to Oxy 5mg q4h PRN for longer effect and scheduled Tramadol 100mg q8h and Acetaminophen 1000mg q8h. If her pain continues, she can f/u with her Neurologist/Ophthalmologist. She received IVIG for 3days and will completed the remaining 2days tx at outpt infusion center. Pt passed the road test without any difficulty and is stable for d/c home.  Reason for Hospital Admission (Admitting Diagnosis):  Myasthenia Gravis flare up
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid ptosis, Full blood count normal, Headache, Immunoglobulin therapy, Intensive care
Clinical narrative: 58 Y female with PMH of Graves Disease s/p thymectomy via median sternotomy (12/2012) on pyridostigmine, generalized anxiety disorder, and hx of frequent hospitalizations for myasthenia gravis flare ups transferred to the ICU on 8/5/2022 for myasthenia crisis. Patient states that she felt typical symptoms of her myasthenia crisis (weakness in her extremities, shortness of breath, and severe pain behind her left eye + blurry vision/diploplia) 40 minutes after receiving the Moderna vaccine this morning.   Per chart review, she has a recent history of hospitalization for myasthenia crisis s/p 3rd dose of Covid vaccine from 12/1/21 - 12/5/21 and other recent hospitalizations for regular flare ups from March 2022 and June 2022. The plan on discharge after her Covid induced flare up was to follow up with neurology prior to her next shot.   Compared to her previous flare up after a covid vaccine, she states that this episode has a quicker onset and she has less shortness of breath. Of note, she has been unable to take her PTA mestinon for the past 10 days after running out of her medications.   Endorses HA, eye pain Denies SOB, abd pain, chest pain, chills, nausea, vomiting, dysuria. Other ROS are negative unless otherwise stated in the HPI. Pt's NIF improved to -40 by next day with BLE weakness resolved and was stable to be transferred to the floors. Pt still had some residual L eye ptosis and pain, but no longer had any diplopia. Next day, pt's L eye ptosis has resolved completely, but she continued to have L eye pain. Pt initially was on: acetaminophen, PTA tramadol 50mg q6h, dialudid 0.2mg q4h PRN. However, pt's pain was still not controlled when dilaudid 0.2mg was changed to Oxy 5mg q4h PRN for longer effect and scheduled Tramadol 100mg q8h and Acetaminophen 1000mg q8h. If her pain continues, she can f/u with her Neurologist/Ophthalmologist. She received IVIG for 3days and will completed the remaining 2days tx at outpt infusion center. Pt passed the road test without any difficulty and is stable for d/c home.  Reason for Hospital Admission (Admitting Diagnosis):  Myasthenia Gravis flare up
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test normal, Muscular weakness, Myasthenia gravis, Myasthenia gravis crisis, Therapeutic product effect decreased
Clinical narrative: 58 Y female with PMH of Graves Disease s/p thymectomy via median sternotomy (12/2012) on pyridostigmine, generalized anxiety disorder, and hx of frequent hospitalizations for myasthenia gravis flare ups transferred to the ICU on 8/5/2022 for myasthenia crisis. Patient states that she felt typical symptoms of her myasthenia crisis (weakness in her extremities, shortness of breath, and severe pain behind her left eye + blurry vision/diploplia) 40 minutes after receiving the Moderna vaccine this morning.   Per chart review, she has a recent history of hospitalization for myasthenia crisis s/p 3rd dose of Covid vaccine from 12/1/21 - 12/5/21 and other recent hospitalizations for regular flare ups from March 2022 and June 2022. The plan on discharge after her Covid induced flare up was to follow up with neurology prior to her next shot.   Compared to her previous flare up after a covid vaccine, she states that this episode has a quicker onset and she has less shortness of breath. Of note, she has been unable to take her PTA mestinon for the past 10 days after running out of her medications.   Endorses HA, eye pain Denies SOB, abd pain, chest pain, chills, nausea, vomiting, dysuria. Other ROS are negative unless otherwise stated in the HPI. Pt's NIF improved to -40 by next day with BLE weakness resolved and was stable to be transferred to the floors. Pt still had some residual L eye ptosis and pain, but no longer had any diplopia. Next day, pt's L eye ptosis has resolved completely, but she continued to have L eye pain. Pt initially was on: acetaminophen, PTA tramadol 50mg q6h, dialudid 0.2mg q4h PRN. However, pt's pain was still not controlled when dilaudid 0.2mg was changed to Oxy 5mg q4h PRN for longer effect and scheduled Tramadol 100mg q8h and Acetaminophen 1000mg q8h. If her pain continues, she can f/u with her Neurologist/Ophthalmologist. She received IVIG for 3days and will completed the remaining 2days tx at outpt infusion center. Pt passed the road test without any difficulty and is stable for d/c home.  Reason for Hospital Admission (Admitting Diagnosis):  Myasthenia Gravis flare up
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin, Vision blurred
Clinical narrative: 58 Y female with PMH of Graves Disease s/p thymectomy via median sternotomy (12/2012) on pyridostigmine, generalized anxiety disorder, and hx of frequent hospitalizations for myasthenia gravis flare ups transferred to the ICU on 8/5/2022 for myasthenia crisis. Patient states that she felt typical symptoms of her myasthenia crisis (weakness in her extremities, shortness of breath, and severe pain behind her left eye + blurry vision/diploplia) 40 minutes after receiving the Moderna vaccine this morning.   Per chart review, she has a recent history of hospitalization for myasthenia crisis s/p 3rd dose of Covid vaccine from 12/1/21 - 12/5/21 and other recent hospitalizations for regular flare ups from March 2022 and June 2022. The plan on discharge after her Covid induced flare up was to follow up with neurology prior to her next shot.   Compared to her previous flare up after a covid vaccine, she states that this episode has a quicker onset and she has less shortness of breath. Of note, she has been unable to take her PTA mestinon for the past 10 days after running out of her medications.   Endorses HA, eye pain Denies SOB, abd pain, chest pain, chills, nausea, vomiting, dysuria. Other ROS are negative unless otherwise stated in the HPI. Pt's NIF improved to -40 by next day with BLE weakness resolved and was stable to be transferred to the floors. Pt still had some residual L eye ptosis and pain, but no longer had any diplopia. Next day, pt's L eye ptosis has resolved completely, but she continued to have L eye pain. Pt initially was on: acetaminophen, PTA tramadol 50mg q6h, dialudid 0.2mg q4h PRN. However, pt's pain was still not controlled when dilaudid 0.2mg was changed to Oxy 5mg q4h PRN for longer effect and scheduled Tramadol 100mg q8h and Acetaminophen 1000mg q8h. If her pain continues, she can f/u with her Neurologist/Ophthalmologist. She received IVIG for 3days and will completed the remaining 2days tx at outpt infusion center. Pt passed the road test without any difficulty and is stable for d/c home.  Reason for Hospital Admission (Admitting Diagnosis):  Myasthenia Gravis flare up
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Malaise, SARS-CoV-2 test positive
Clinical narrative: Chronically ill patient resident of Rehab tested positive for Covid-19 on 01/17/2022 at facility.  Patient expired on 01/30/2022.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial flutter, Cardioversion
Clinical narrative: Atrial flutter admitted to hospital cardioverted sent home on medicine
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given after Beyond use date. No reactions were reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Arteriosclerosis, COVID-19, Condition aggravated
Clinical narrative: 11/29/21 pt to ED from Hospice with worsening dyspnea; EMS transported pt; in ED found to be hypoxic with O2 sats in 70s, positive for COVID, hypertensive, acute on chronic kidney injury, pulmonary edema, pleural effusion, emphysema, extensive atherosclerotic disease; pt intubated and transferred to MICU; given dexamethasone; found to have brachial DVT, started on Heparin; pt has had several hospitalizations in pas for pulmonary edema and renal failure; family decided to have pt extubated and DNR/DNI with comfort measures; moved to PCU where he expired
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Emphysema, Endotracheal intubation, Hypertension
Clinical narrative: 11/29/21 pt to ED from Hospice with worsening dyspnea; EMS transported pt; in ED found to be hypoxic with O2 sats in 70s, positive for COVID, hypertensive, acute on chronic kidney injury, pulmonary edema, pleural effusion, emphysema, extensive atherosclerotic disease; pt intubated and transferred to MICU; given dexamethasone; found to have brachial DVT, started on Heparin; pt has had several hospitalizations in pas for pulmonary edema and renal failure; family decided to have pt extubated and DNR/DNI with comfort measures; moved to PCU where he expired